What is the main business of TDF?

The main business activity of TDF focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 25, 2010.

Where is the headquarters located?

The headquarters is located at: ul. Zbąszyńska 3, 91-342 Łódź.

Who is on the management board?

The management board consists of: Jana Nowak Blahová (Vice President of the Management Board), Krzysztof Mirosław Głąbica (Vice President of the Management Board), and Jędrzej Krzysztof Kosiński (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 27,100,000 (approx. $7.3 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $5,168,316, representing a decrease of 90.7% compared to 2023.

Is the company profitable?

Yes, the company recorded a net profit of $148,620 in 2024, meaning the company decreased its profit by 87.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $2,889,957 in 2024, representing 60% of all operating expenses.

TDFS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2010-10-25

Share capital

27 100 000,00 PLN

Activity description

Tdf is part of the Pelion S.A. group, the largest company in the healthcare sector in Poland. The company is involved in managing shareholder registers through an agreement with PKO BP BM, which also handles financial obligations to its shareholders. Additionally, Tdf is classified as a large enterprise under EU regulations.

Registered address

ul. Zbąszyńska 3, 91-342 Łódź, Poland

Website

tdfsa.pl

Phone

Electronic delivery address

AE:PL-30479-91324-RERUT-09

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.99mMedianUSD 873.84kAverageUSD 20.03m

Net profit

This companyUSD 548.11kMedianUSD 28.21kAverageUSD 815.54k

Operating costs

This companyUSD 1.29mMedianUSD 801.08kAverageUSD 18.78m

Assets

This companyUSD 8.43mMedianUSD 539.29kAverageUSD 10.66m

Industry

Bank accounts

Registered as a VAT taxpayer on 2010-11-10. Active

BNP Paribas Bank Polska
72 1600 0003 1843 4786 7000 0029
BNP Paribas Bank Polska
53 1600 1462 1843 4786 7000 0026
BNP Paribas Bank Polska
43 1600 1143 1843 4786 7000 0002

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication date	Event
Feb 5, 2021	Lost documents
Aug 9, 2016	Merger registered
Aug 9, 2016	Commercial Companies Code notice

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Jana Nowak Blahová — Vice President of the Management Board

Izabela Ewa Walasik — Attorney-in-fact (joint)

Krzysztof Mirosław Głąbica — Vice President of the Management Board

Jędrzej Krzysztof Kosiński — President of the Management Board

Monika Kluczyk — Attorney-in-fact (joint)

Manner of representation

The persons authorised to make declarations of will on behalf of the company are: 2 (two) members of the management board acting jointly, or 1 (one) member of the management board jointly with a commercial proxy.

Supervisory board

Mariola Belina Prażmowska — Supervisory Board Member

Jacek Dauenhauer — Supervisory Board Member

Ignacy Przystalski — Supervisory Board Member

Zbigniew Jacek Molenda — Supervisory Board Member

Beneficial owners

Person	Rights
Zbigniew Jacek Molenda (63)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczy udziałów lub akcji spółki
Jacek Szwajcowski (62)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczy udziałów lub akcji spółki

Subsidiaries

	Name	Share value	Stake
	Dospirosp. z o.o.	3,637,763.37 USD	50%

Competitors

	Name	Revenue	Website
	ProasisstansS.K.A.	$13,360,980.99	maxto.pl

Change history

Date	Event
2023-12-01	Name change (Pharmapoint → Tdf)
2021-05-27	Share capital change (193,100,000.00 PLN → 27,100,000.00 PLN)
2017-07-21	Share capital change (182,100,000.00 PLN → 193,100,000.00 PLN)
2017-02-17	Address change (Władysława Węgorka 15, 60-318, Poznań → Ul. Zbąszyńska 3, 91-342, Łódź)
2016-07-26	Share capital change (1,000,000.00 PLN → 182,100,000.00 PLN)

FAQ

Last updated: 2026-09-30